NFA
KYTH

Nationwide Fund Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Nationwide Fund Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,700
Closed -$1.25M – 3342
2015
Q3 		$1.25M Sell
16,700
-7,500
-31% -$560K 0.01% 1611
2015
Q2 		$1.82M Sell
24,200
-1,056
-4% -$56.6K 0.01% 1486
2015
Q1 		$1.27M Buy
25,256
+12,023
+91% +$505K 0.01% 1764
2014
Q4 		$459K Sell
13,233
-149
-1% -$5.2K ﹤0.01% 2231
2014
Q3 		$438K Buy
13,382
+51
+0.4% +$1.8K ﹤0.01% 2287
2014
Q2 		$512K Buy
13,331
+4,269
+47% +$149K ﹤0.01% 2249
2014
Q1 		$360K Sell
9,062
-3,064
-25% -$137K ﹤0.01% 2217
2013
Q4 		$452K Buy
12,126
+1,000
+9% +$41.5K ﹤0.01% 2289
2013
Q3 		$508K Buy
11,126
+5,682
+104% +$170K ﹤0.01% 2207
2013
Q2 		$147K Buy
+5,444
New +$125K ﹤0.01% 2639

Nationwide Fund Advisors's KYTH Position: Q4 2015 in Review

Nationwide Fund Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 16,700 shares — an estimated $1.25M sold.

Nationwide Fund Advisors first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $1.82M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Nationwide Fund Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 16,700 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.25M.
  • Nationwide Fund Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Nationwide Fund Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.82M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Nationwide Fund Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.